The model's full reasoning — Q4 2022 call → NOThe question asks whether management reports that the company's physical or operational output has just reached the highest level in its own history or a clear step above its prior operating range, grounded in specific operating quantities or milestones actually achieved in the recent period, AND indicates that output is expected to continue rising because drivers are still building. Let me examine the transcript carefully. The company is Arrowhead Pharmaceuticals, a biotech company developing RNAi therapeutics. Their "output" in operational terms would be things like drug candidates in clinical trials, pipeline progress, patients treated, etc. The transcript mentions "20 in '25" program - a plan to have 20 individual drug candidates in clinical trials or in the market in 2025. But this is a forward-looking plan, not something already achieved. The CEO mentions "12 drug candidates in clinical trials" currently - that's the current state, but is this described as a record or step-change? Let me look more carefully. The transcript discusses: - Progress on multiple Phase 3 programs - Pipeline of 12 drug candidates in clinical trials - Plans for 20 in '25 - Various clinical trial progress But is there any specific statement about physical/operational output reaching the highest level in company history? The company is a biotech, so "output" might be measured in terms of clinical candidates, patients dosed, etc. The question asks: does management report that output JUST REACHED THE HIGHEST LEVEL in company history or a clear step above prior range? The transcript talks about pipeline size (12 candidates), plans for future growth (20 in '25), but I don't see management explicitly stating that some operational metric has just reached a record high or clear step-change in the just-reported period. Let me check key phrases: - "clear progress across our large and balanced pipeline" - "now includes 12 drug candidates in clinical trials" - "20 in '25 program" - this is a future target The 20 in '25 is a goal, not something achieved. The 12 candidates is the current state but I don't see management framing this as a record or step-change above prior operating range. Management does say the plan is to have 20 in 2025, which means higher output is forecast/targeted, not achieved.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| CRGO | Freightos Limited | Q1 2024 | 2024-05-20 | C+ |
| PBR | Petróleo Brasileiro S.A. - Petrobras | Q4 2023 | 2024-03-08 | D |
| MNKD | MannKind Corporation | Q4 2023 | 2024-02-27 | C |
| DXCM | DexCom, Inc. | Q4 2023 | 2024-02-08 | B+ |
| GPRE | Green Plains Inc. | Q4 2023 | 2024-02-07 | F |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| ET | Energy Transfer LP | Q2 2023 | 2023-08-02 | C+ |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| BKH | Black Hills Corporation | Q4 2022 | 2023-02-08 | D |
| SIBN | SI-BONE, Inc. | Q3 2022 | 2022-11-07 | C+ |
| EXFY | Expensify, Inc. | Q2 2022 | 2022-08-12 | D |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| CCRN | Cross Country Healthcare, Inc. | Q1 2022 | 2022-05-04 | B |
| ZH | Zhihu Inc. | Q3 2021 | 2021-11-22 | D |
| RNW | ReNew Energy Global Plc | Q2 2022 | 2021-11-18 | C |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| OGE | OGE Energy Corp. | Q3 2018 | 2018-11-08 | A |
| CP | Canadian Pacific Railway Limited | Q2 2018 | 2018-07-19 | B+ |
| HOLX | Hologic, Inc. | Q4 2017 | 2017-11-08 | D |
| CCOI | Cogent Communications Holdings, Inc. | Q2 2017 | 2017-08-03 | B |
| ABR | Arbor Realty Trust, Inc. | Q4 2016 | 2017-03-03 | B+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
| HD | The Home Depot, Inc. | Q4 2015 | 2016-02-23 | A |
SIBN · Q3 2022 → YESThe question is about whether management reports that the company's physical or operational output has just reached the highest level in the company's history or a clear step above its prior operating...YES The transcript explicitly states "25% growth in procedure volumes versus the prior year period" and "record active surgeon base of over 800 surgeons," framing these as achieved milestones in the just-reported quarter. Management ties the growth to ongoing demand drivers ("continued acceleration in procedure demand"), indicating the level is a waypoint rather than a peak, with output expected to continue rising as the same drivers persist. This constitutes a clear step above prior operating range in physical activity (procedures performed), grounded in recent operating quantities and sustained by building capacity/customers.
BRX · Q1 2023 → YESThe question is about whether management reports that the company's PHYSICAL OR OPERATIONAL OUTPUT has just reached the highest level in the company's history or a clear step above its prior operating...NO The transcript shows management highlighting record occupancy levels (94% overall and 89.3% for small shops) as well as leasing activity and signed leases, but these are framed as utilization or pipeline metrics rather than a record level of physical output such as units produced, shipped, delivered, opened, or performed.
CRGO · Q1 2024 → YESThe question is about whether management reports that the company's physical or operational output has just reached the highest level in the company's history or a clear step above its prior operating...